Sfoglia per Autore
Prior antibiotics, proton pump inhibitors, and probiotics in patients with extensive stage small cell lung cancer treated with immune checkpoint blockade: A post-hoc analysis of the phase I/III IMpower 133 trial
2025-01-01 Takada, K.; Takamori, S.; Shimokawa, M.; Pinato, D. J.; Cortellini, A.
Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study
2025-01-01 Lombardi, Pasquale; Kim, Jung Sun; Manfredi, Giulia F.; Celsa, Ciro; Fulgenzi, Claudia A. M.; D'Alessio, Antonio; Stefanini, Bernardo; Doshi, Niraj C.; Warmington, Emily; Marron, Thomas U.; Pinter, Matthias; Scheiner, Bernhard; Kang, Beodeul; Lim, Ho Yeong; Hsu, Wei-Fan; Wietharn, Brooke; Silletta, Marianna; Parisi, Alessandro; Lin, Chun-Yen; Dalbeni, Andrea; Masi, Gianluca; Schönlein, Martin; Von Felden, Johann; Piscaglia, Fabio; Galle, Peter R.; Kudo, Masatoshi; Pressiani, Tiziana; Rimassa, Lorenza; Pirisi, Mario; Cabibbo, Giuseppe; Chon, Hong Jae; Pinato, David J.
Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence
2025-01-01 Manfredi, Giulia Francesca; Fulgenzi, Claudia Angela Maria; Celsa, Ciro; Stefanini, Bernardo; D'Alessio, Antonio; Pinter, Matthias; Scheiner, Bernhard; Awosika, Nichola; Brunetti, Leonardo; Lombardi, Pasquale; Latchford, Charles; Lee, Pei-Chang; Huang, Yi-Hsiang; Lin, Chun-Yen; Dalbeni, Andrea; Vogel, Arndt; Galle, Peter R.; Kudo, Masatoshi; Rimassa, Lorenza; Chon, Hong Jae; Cabibbo, Giuseppe; Piscaglia, Fabio; Cammà, Calogero; Pillai, Anjana; Pirisi, Mario; Singal, Amit G.; Pinato, David J.
Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis
2025-01-01 Celsa, Ciro; Di Maria, Gabriele; Lombardi, Pasquale; D'Alessio, Antonio; Fulgenzi, Claudia A M; Brunetti, Leonardo; Manfredi, Giulia F; Stefanini, Bernardo; Sparacino, Alba; Rigamonti, Cristina; Pirisi, Mario; Latchford, Charles; Vaccaro, Marco; Enea, Marco; Cammà, Calogero; Cabibbo, Giuseppe; Pinato, David James
ctDNA: A Gateway for Personalized Risk Stratification in Surgically Resectable Hepatocellular Cancer
2025-01-01 Pinato, David J; Lombardi, Pasquale; D'Alessio, Antonio; Torkpour, Aria; Fulgenzi, Claudia Angela Maria; Brunetti, Leonardo
Single-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma
2024-01-01 Cappuyns, Sarah; Piqué-Gili, Marta; Esteban-Fabró, Roger; Philips, Gino; Balaseviciute, Ugne; Pinyol, Roser; Gris-Oliver, Albert; Vandecaveye, Vincent; Abril-Fornaguera, Jordi; Montironi, Carla; Bassaganyas, Laia; Peix, Judit; Zeitlhoefler, Marcus; Mesropian, Agavni; Huguet-Pradell, Júlia; Haber, Philipp K; Figueiredo, Igor; Ioannou, Giorgio; Gonzalez-Kozlova, Edgar; D'Alessio, Antonio; Mohr, Raphael; Meyer, Tim; Lachenmayer, Anja; Marquardt, Jens U; Reeves, Helen L; Edeline, Julien; Finkelmeier, Fabian; Trojan, Jörg; Galle, Peter R; Foerster, Friedrich; Mínguez, Beatriz; Montal, Robert; Gnjatic, Sacha; Pinato, David J; Heikenwalder, Mathias; Verslype, Chris; Van Cutsem, Eric; Lambrechts, Diether; Villanueva, Augusto; Dekervel, Jeroen; Llovet, Josep M
Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter?
2024-01-01 Smirne, Carlo; Crobu, Maria Grazia; Landi, Irene; Vercellino, Nicole; Apostolo, Daria; Pinato, David James; Vincenzi, Federica; Minisini, Rosalba; Tonello, Stelvio; D'Onghia, Davide; Ottobrelli, Antonio; Martini, Silvia; Bracco, Christian; Fenoglio, Luigi Maria; Campanini, Mauro; Berton, Alessandro Maria; Ciancio, Alessia; Pirisi, Mario
Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma
2024-01-01 Salie, H.; Wischer, L.; D'Alessio, A.; Godbole, I.; Suo, Y.; Otto-Mora, P.; Beck, J.; Neumann, O.; Stenzinger, A.; Schirmacher, P.; Fulgenzi, C. A. M.; Blaumeiser, A.; Boerries, M.; Roehlen, N.; Schultheiss, M.; Hofmann, M.; Thimme, R.; Pinato, D. J.; Longerich, T.; Bengsch, B.
Merits and boundaries of the BCLC staging and treatment algorithm: Learning from the past to improve the future with a novel proposal
2024-01-01 Trevisani, F.; Vitale, A.; Kudo, M.; Kulik, L.; Park, J. -W.; Pinato, D. J.; Cillo, U.
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours
2024-01-01 Celsa, C.; Cabibbo, G.; Fulgenzi, C. A. M.; Scheiner, B.; D'Alessio, A.; Manfredi, G. F.; Nishida, N.; Ang, C.; Marron, T. U.; Saeed, A.; Wietharn, B.; Pinter, M.; Cheon, J.; Huang, Y. -H.; Lee, P. -C.; Phen, S.; Gampa, A.; Pillai, A.; Vivaldi, C.; Salani, F.; Masi, G.; Roehlen, N.; Thimme, R.; Vogel, A.; Schonlein, M.; von Felden, J.; Schulze, K.; Wege, H.; Galle, P. R.; Kudo, M.; Rimassa, L.; Singal, A. G.; El Tomb, P.; Ulahannan, S.; Parisi, A.; Chon, H. J.; Hsu, W. -F.; Stefanini, B.; Verzoni, E.; Giusti, R.; Veccia, A.; Catino, A.; Aprile, G.; Guglielmini, P. F.; Di Napoli, M.; Ermacora, P.; Antonuzzo, L.; Rossi, E.; Verderame, F.; Zustovich, F.; Ficorella, C.; Di Pietro, F. R.; Battelli, N.; Negrini, G.; Grossi, F.; Bordonaro, R.; Pipitone, S.; Banzi, M.; Ricciardi, S.; Laera, L.; Russo, A.; De Giorgi, U.; Cavanna, L.; Soraru, M.; Montesarchio, V.; Bordi, P.; Brunetti, L.; Pinto, C.; Bersanelli, M.; Camma, C.; Cortellini, A.; Pinato, D. J.
Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213)
2024-01-01 Jin, Z. -C.; Zhou, J. -W.; Chen, J. -J.; Ding, R.; Scheiner, B.; Wang, S. -N.; Li, H. -L.; Shen, Q. -X.; Lu, Q. -Y.; Liu, Y.; Zhang, W. -H.; Luo, B.; Shi, H. -B.; Huang, M.; Wu, Y. -M.; Yuan, C. -W.; Huang, M. -S.; Li, J. -P.; Wu, J. -B.; Zhu, X. -L.; Zhong, B. -Y.; Zhou, H. -F.; Wang, Y. -Q.; Gu, S. -Z.; Peng, Z. -Y.; Zheng, C. -S.; Liu, R. -B.; Xu, G. -H.; Yang, W. -Z.; Xu, A. -B.; Liu, D. -F.; Qi, X.; Yeo, Y.; Zhu, H. -D.; Zhao, Y.; Pinato, D.; Ji, F.; Teng, G. -J.
Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study
2024-01-01 Fletcher, K.; Cortellini, A.; Ganta, T.; Kankaria, R.; Song, H.; Ye, F.; Irlmeier, R.; Debnath, N.; Saeed, A.; Radford, M.; Alahmadi, A.; Diamond, A.; Hoimes, C.; Presley, C. J.; Owen, D. H.; Abou Alaiwi, S.; Nassar, A. H.; Lamberti, G.; Perrone, F.; Buti, S.; Giusti, R.; Filetti, M.; Vanella, V.; Mallardo, D.; Sussman, T. A.; Galetta, D.; Kalofonou, F.; Daniels, E.; Ascierto, P. A.; Pinato, D. J.; Nebhan, C.; Berg, S.; Choueiri, T. K.; Marron, T. U.; Wang, Y.; Naqash, A. R.; Johnson, D. B.
Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients
2024-01-01 Wang, Y.; Abu-Sbeih, H.; Tang, T.; Shatila, M.; Faleck, D.; Harris, J.; Dougan, M.; Olsson-Brown, A.; Johnson, D. B.; Shi, C.; Grivas, P.; Diamantopoulos, L.; Owen, D. H.; Cassol, C.; Arnold, C. A.; Warner, D. E.; Alva, A.; Powell, N.; Ibraheim, H.; De Toni, E. N.; Philipp, A. B.; Philpott, J.; Sleiman, J.; Lythgoe, M.; Daniels, E.; Sandhu, S.; Weppler, A. M.; Buckle, A.; Pinato, D. J.; Thomas, A.; Qiao, W.
Reply to: “Evidence and choice: The BCLC vision for tailoring clinical decision-making”
2024-01-01 Trevisani, F.; Vitale, A.; Colli, A.; Kudo, M.; Kulik, L.; Park, J. -W.; Pinato, D. J.; Cillo, U.
Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver Malignancy
2024-01-01 Kennedy, A. S.; Brown, D. B.; Fakih, M.; Jeyarajah, R.; Jones, S.; Liu, D.; Pinato, D. J.; Sangro, B.; Sharma, N. K.; Sze, D. Y.; Van Cutsem, E.; Wasan, H. S.
The role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapy
2024-01-01 Dean, N. J.; D'Arienzo, P. D.; Ibraheim, H.; Lee, K. A.; Olsson-Brown, A. C.; Pinato, D. J.; Powell, N.
Reply to: “irLI or not irLI: That is the question”
2024-01-01 Celsa, C.; Cabibbo, G.; Pinato, D. J.
New Scenarios in Liver Transplantation for Hepatocellular Carcinoma
2024-01-01 Mauro, E.; Rodriguez-Peralvarez, M.; D'Alessio, A.; Crespo, G.; Pinero, F.; Demartin, E.; Colmenero, J.; Pinato, D.; Forner, A.
Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events
2024-01-01 De Martin, E.; Fulgenzi, C. A. M.; Celsa, C.; Laurent-Bellue, A.; Torkpour, A.; Lombardi, P.; D'Alessio, A.; Pinato, D. J.
Safety and efficacy of itacitinib, a selective JAK1 inhibitor, in advanced hepatocellular cancer: Phase 1b trial (JAKAL)
2024-01-01 Troiani, A.; Martinez, M.; Ward, C.; Benartzi, C. W.; Pinato, D. J.; Sharma, R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Prior antibiotics, proton pump inhibitors, and probiotics in patients with extensive stage small cell lung cancer treated with immune checkpoint blockade: A post-hoc analysis of the phase I/III IMpower 133 trial | 1-gen-2025 | Takada, K.; Takamori, S.; Shimokawa, M.; Pinato, D. J.; Cortellini, A. | |
| Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study | 1-gen-2025 | Lombardi, Pasquale; Kim, Jung Sun; Manfredi, Giulia F.; Celsa, Ciro; Fulgenzi, Claudia A. M.; D'Alessio, Antonio; Stefanini, Bernardo; Doshi, Niraj C.; Warmington, Emily; Marron, Thomas U.; Pinter, Matthias; Scheiner, Bernhard; Kang, Beodeul; Lim, Ho Yeong; Hsu, Wei-Fan; Wietharn, Brooke; Silletta, Marianna; Parisi, Alessandro; Lin, Chun-Yen; Dalbeni, Andrea; Masi, Gianluca; Schönlein, Martin; Von Felden, Johann; Piscaglia, Fabio; Galle, Peter R.; Kudo, Masatoshi; Pressiani, Tiziana; Rimassa, Lorenza; Pirisi, Mario; Cabibbo, Giuseppe; Chon, Hong Jae; Pinato, David J. | |
| Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence | 1-gen-2025 | Manfredi, Giulia Francesca; Fulgenzi, Claudia Angela Maria; Celsa, Ciro; Stefanini, Bernardo; D'Alessio, Antonio; Pinter, Matthias; Scheiner, Bernhard; Awosika, Nichola; Brunetti, Leonardo; Lombardi, Pasquale; Latchford, Charles; Lee, Pei-Chang; Huang, Yi-Hsiang; Lin, Chun-Yen; Dalbeni, Andrea; Vogel, Arndt; Galle, Peter R.; Kudo, Masatoshi; Rimassa, Lorenza; Chon, Hong Jae; Cabibbo, Giuseppe; Piscaglia, Fabio; Cammà, Calogero; Pillai, Anjana; Pirisi, Mario; Singal, Amit G.; Pinato, David J. | |
| Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis | 1-gen-2025 | Celsa, Ciro; Di Maria, Gabriele; Lombardi, Pasquale; D'Alessio, Antonio; Fulgenzi, Claudia A M; Brunetti, Leonardo; Manfredi, Giulia F; Stefanini, Bernardo; Sparacino, Alba; Rigamonti, Cristina; Pirisi, Mario; Latchford, Charles; Vaccaro, Marco; Enea, Marco; Cammà, Calogero; Cabibbo, Giuseppe; Pinato, David James | |
| ctDNA: A Gateway for Personalized Risk Stratification in Surgically Resectable Hepatocellular Cancer | 1-gen-2025 | Pinato, David J; Lombardi, Pasquale; D'Alessio, Antonio; Torkpour, Aria; Fulgenzi, Claudia Angela Maria; Brunetti, Leonardo | |
| Single-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma | 1-gen-2024 | Cappuyns, Sarah; Piqué-Gili, Marta; Esteban-Fabró, Roger; Philips, Gino; Balaseviciute, Ugne; Pinyol, Roser; Gris-Oliver, Albert; Vandecaveye, Vincent; Abril-Fornaguera, Jordi; Montironi, Carla; Bassaganyas, Laia; Peix, Judit; Zeitlhoefler, Marcus; Mesropian, Agavni; Huguet-Pradell, Júlia; Haber, Philipp K; Figueiredo, Igor; Ioannou, Giorgio; Gonzalez-Kozlova, Edgar; D'Alessio, Antonio; Mohr, Raphael; Meyer, Tim; Lachenmayer, Anja; Marquardt, Jens U; Reeves, Helen L; Edeline, Julien; Finkelmeier, Fabian; Trojan, Jörg; Galle, Peter R; Foerster, Friedrich; Mínguez, Beatriz; Montal, Robert; Gnjatic, Sacha; Pinato, David J; Heikenwalder, Mathias; Verslype, Chris; Van Cutsem, Eric; Lambrechts, Diether; Villanueva, Augusto; Dekervel, Jeroen; Llovet, Josep M | |
| Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter? | 1-gen-2024 | Smirne, Carlo; Crobu, Maria Grazia; Landi, Irene; Vercellino, Nicole; Apostolo, Daria; Pinato, David James; Vincenzi, Federica; Minisini, Rosalba; Tonello, Stelvio; D'Onghia, Davide; Ottobrelli, Antonio; Martini, Silvia; Bracco, Christian; Fenoglio, Luigi Maria; Campanini, Mauro; Berton, Alessandro Maria; Ciancio, Alessia; Pirisi, Mario | |
| Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma | 1-gen-2024 | Salie, H.; Wischer, L.; D'Alessio, A.; Godbole, I.; Suo, Y.; Otto-Mora, P.; Beck, J.; Neumann, O.; Stenzinger, A.; Schirmacher, P.; Fulgenzi, C. A. M.; Blaumeiser, A.; Boerries, M.; Roehlen, N.; Schultheiss, M.; Hofmann, M.; Thimme, R.; Pinato, D. J.; Longerich, T.; Bengsch, B. | |
| Merits and boundaries of the BCLC staging and treatment algorithm: Learning from the past to improve the future with a novel proposal | 1-gen-2024 | Trevisani, F.; Vitale, A.; Kudo, M.; Kulik, L.; Park, J. -W.; Pinato, D. J.; Cillo, U. | |
| Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours | 1-gen-2024 | Celsa, C.; Cabibbo, G.; Fulgenzi, C. A. M.; Scheiner, B.; D'Alessio, A.; Manfredi, G. F.; Nishida, N.; Ang, C.; Marron, T. U.; Saeed, A.; Wietharn, B.; Pinter, M.; Cheon, J.; Huang, Y. -H.; Lee, P. -C.; Phen, S.; Gampa, A.; Pillai, A.; Vivaldi, C.; Salani, F.; Masi, G.; Roehlen, N.; Thimme, R.; Vogel, A.; Schonlein, M.; von Felden, J.; Schulze, K.; Wege, H.; Galle, P. R.; Kudo, M.; Rimassa, L.; Singal, A. G.; El Tomb, P.; Ulahannan, S.; Parisi, A.; Chon, H. J.; Hsu, W. -F.; Stefanini, B.; Verzoni, E.; Giusti, R.; Veccia, A.; Catino, A.; Aprile, G.; Guglielmini, P. F.; Di Napoli, M.; Ermacora, P.; Antonuzzo, L.; Rossi, E.; Verderame, F.; Zustovich, F.; Ficorella, C.; Di Pietro, F. R.; Battelli, N.; Negrini, G.; Grossi, F.; Bordonaro, R.; Pipitone, S.; Banzi, M.; Ricciardi, S.; Laera, L.; Russo, A.; De Giorgi, U.; Cavanna, L.; Soraru, M.; Montesarchio, V.; Bordi, P.; Brunetti, L.; Pinto, C.; Bersanelli, M.; Camma, C.; Cortellini, A.; Pinato, D. J. | |
| Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213) | 1-gen-2024 | Jin, Z. -C.; Zhou, J. -W.; Chen, J. -J.; Ding, R.; Scheiner, B.; Wang, S. -N.; Li, H. -L.; Shen, Q. -X.; Lu, Q. -Y.; Liu, Y.; Zhang, W. -H.; Luo, B.; Shi, H. -B.; Huang, M.; Wu, Y. -M.; Yuan, C. -W.; Huang, M. -S.; Li, J. -P.; Wu, J. -B.; Zhu, X. -L.; Zhong, B. -Y.; Zhou, H. -F.; Wang, Y. -Q.; Gu, S. -Z.; Peng, Z. -Y.; Zheng, C. -S.; Liu, R. -B.; Xu, G. -H.; Yang, W. -Z.; Xu, A. -B.; Liu, D. -F.; Qi, X.; Yeo, Y.; Zhu, H. -D.; Zhao, Y.; Pinato, D.; Ji, F.; Teng, G. -J. | |
| Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study | 1-gen-2024 | Fletcher, K.; Cortellini, A.; Ganta, T.; Kankaria, R.; Song, H.; Ye, F.; Irlmeier, R.; Debnath, N.; Saeed, A.; Radford, M.; Alahmadi, A.; Diamond, A.; Hoimes, C.; Presley, C. J.; Owen, D. H.; Abou Alaiwi, S.; Nassar, A. H.; Lamberti, G.; Perrone, F.; Buti, S.; Giusti, R.; Filetti, M.; Vanella, V.; Mallardo, D.; Sussman, T. A.; Galetta, D.; Kalofonou, F.; Daniels, E.; Ascierto, P. A.; Pinato, D. J.; Nebhan, C.; Berg, S.; Choueiri, T. K.; Marron, T. U.; Wang, Y.; Naqash, A. R.; Johnson, D. B. | |
| Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients | 1-gen-2024 | Wang, Y.; Abu-Sbeih, H.; Tang, T.; Shatila, M.; Faleck, D.; Harris, J.; Dougan, M.; Olsson-Brown, A.; Johnson, D. B.; Shi, C.; Grivas, P.; Diamantopoulos, L.; Owen, D. H.; Cassol, C.; Arnold, C. A.; Warner, D. E.; Alva, A.; Powell, N.; Ibraheim, H.; De Toni, E. N.; Philipp, A. B.; Philpott, J.; Sleiman, J.; Lythgoe, M.; Daniels, E.; Sandhu, S.; Weppler, A. M.; Buckle, A.; Pinato, D. J.; Thomas, A.; Qiao, W. | |
| Reply to: “Evidence and choice: The BCLC vision for tailoring clinical decision-making” | 1-gen-2024 | Trevisani, F.; Vitale, A.; Colli, A.; Kudo, M.; Kulik, L.; Park, J. -W.; Pinato, D. J.; Cillo, U. | |
| Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver Malignancy | 1-gen-2024 | Kennedy, A. S.; Brown, D. B.; Fakih, M.; Jeyarajah, R.; Jones, S.; Liu, D.; Pinato, D. J.; Sangro, B.; Sharma, N. K.; Sze, D. Y.; Van Cutsem, E.; Wasan, H. S. | |
| The role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapy | 1-gen-2024 | Dean, N. J.; D'Arienzo, P. D.; Ibraheim, H.; Lee, K. A.; Olsson-Brown, A. C.; Pinato, D. J.; Powell, N. | |
| Reply to: “irLI or not irLI: That is the question” | 1-gen-2024 | Celsa, C.; Cabibbo, G.; Pinato, D. J. | |
| New Scenarios in Liver Transplantation for Hepatocellular Carcinoma | 1-gen-2024 | Mauro, E.; Rodriguez-Peralvarez, M.; D'Alessio, A.; Crespo, G.; Pinero, F.; Demartin, E.; Colmenero, J.; Pinato, D.; Forner, A. | |
| Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events | 1-gen-2024 | De Martin, E.; Fulgenzi, C. A. M.; Celsa, C.; Laurent-Bellue, A.; Torkpour, A.; Lombardi, P.; D'Alessio, A.; Pinato, D. J. | |
| Safety and efficacy of itacitinib, a selective JAK1 inhibitor, in advanced hepatocellular cancer: Phase 1b trial (JAKAL) | 1-gen-2024 | Troiani, A.; Martinez, M.; Ward, C.; Benartzi, C. W.; Pinato, D. J.; Sharma, R. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile